FDA clears Ambu's new bronchoscope generation

The Danish medtech firm is now authorized to sell its newest generation of single-use bronchoscopes both in the EU and the US.

Photo: PR / Ambu

After obtaining the EU’s CE mark for the Ascope 5 Broncho device in May, medtech firm Ambu can now also launch in the US, according to a Tuesday press release.

The US Food and Drug Administration (FDA) has approved the single-use bronchoscope portfolio, which the firm says has more advanced imaging features due to a new high-resolution camera chip.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs